Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 699-700.
• Orginal Article • Previous Articles Next Articles
YU Jin, WU Jingjing, BIAN Hailin*
Received:2018-05-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
YU Jin, WU Jingjing, BIAN Hailin. One Case of Rapid Increase of γ-glutamyltransferase Induced by Biapenem for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 699-700.
Add to citation manager EndNote|Ris|BibTeX
| [1] 赵颖,邹文卫. 比阿培南治疗中重度卒中相关性肺炎疗效观察[J]. 中国实用神经疾病杂志, 2011,14(17):35-38. [2] 赵媛媛,王屏,银洪汝. 碳青霉烯类抗菌药物致不良反应文献分析[J]. 中国药房,2013,24(10):933-935. [3] 国家食品药品监督管理局药品安全监管司, 国家药品不良反应中心. 药品不良反应报告和监测工作手册[S]. 2005:46. [4] 杜文民,王永民,程能能. 药品不良反应的判定与其研究方法[J]. 中国药物警戒,2005,2(1):11-13,28. [5] 魏戌,谢雁. 国内外不良反应因果判断原则及评价方法解读[J]. 中国中药杂志,2012,37(18):2744-2747. [6] 位松华. ALT、AST、ALP、γ-GT组合实验室检验结果分析在各类肝胆疾病诊断中的临床价值[J]. 检验医学与临床,2016,13(6):848-849. [7] Zhang Y, Yu C L, Zhao M, et al.Effects of fluoroquinolones on the cytochrome P450 enzyme system of rat liver microsomes[J]. Med J Chin PLA, 2012,37(11):1059-1063. [8] Ho N, Youjyu K, Hiroyuki Y, et al.The efficacy, safety, and pharmacokinetics of biapenem administered thrice daily for the treatment of pneumonia in the elderly[J]. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy, 2014,20(6):356-360. [9] 李楠,徐正婕. 抗菌药物对肝脏的影响及在肝病治疗中的应用[J]. 世界临床药物,2011,32(9):521-525. [10] 朱磊,黄萍,李颖. 162例药物性肝损害不良反应/事件报告分析[J]. 中国药物警戒,2013,10(7):415-418. [11] 关晓媛,任进强. 浅谈抗菌药物的不良反应及应对措施[J]. 中国保健营养,2012,6(10):1710. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
